Small Cap Feast

28th June 2024

Dish of the day
No Joiners today
Off the menu
No leavers today


Dish Of The Day:


Admissions: 


Delistings: 

Startup Giants (SUG) has withdrawn from Aquis Stock Exchange




Whats baking in the oven?

Potential**** Initial Public Offerings:

ITF announced:

19 June 2024: IntelliAM, an artificial intelligence company focused on the consumer goods industry, is preparing to list on the Aquis Exchange on 3 July. The Company is acquiring 53 Degrees North Engineering Limited, to become the Company’s Consultancy division, which provides a range of asset care consulting and management strategies for manufacturers, particularly in the fast-moving consumer goods (FMCG) sector. The Consultancy division has established relationships with some of the largest food and beverage companies in the world, with 5 out of the top 10 being existing customers. IntelliAM is a revenue generating and profitable company. The Company is looking to raise £5m to fund the Company’s expansion. The Freefloat will be 16.5% following Admission and Completion of the acquisition of 53 North.

24th June 2024: Rosebank Industries: The Company aims to repeat the successful 'Buy, Improve, Sell' business model which the Rosebank Co-Founders implemented during their time at Melrose. Rosebank proposes to acquire quality industrial or manufacturing businesses whose performance may be improved. The Company’s first day of trading on AIM is expected to be 11th July 2024. The primary offer expected size is approximately £50m.

Media speculation: (We remove rumours after 10 days of being on the menu)

19th June 2024: Pri0r1ty AI, a software company, pending regulatory clearance, is expecting to raise at least £600,000 in a public listing on the Aquis Exchange in early July to launch its product

25th June 2024: Reset Health has created an app to connect obesity and type 2 diabetes patients with clinicians. The Company is considering a listing on AIM in a deal that could see the business valued at up to £60m and raise £15m.


Reverse Takeovers:


Change of Market:

Dual Listing :


Banquet Buffet

Angus Energy 0.35p £15.5m (ANGS.L)

The independent onshore Energy Transition company with a portfolio of clean gas development assets, onshore geothermal projects, and legacy oil producing fields announced its interim accounts for the six months ended 31 March 2024. Revenue decreased to £12.13m (H1 2023: £16.47m), profit before tax decreased to £5.78m (H1 2023: £115.30m) and the cash and cash equivalents increased to £5.44m (H1 2023: £3.17m). With the successful restructuring of the Company's debt and stable production at Saltfleetby the management team can now turn attention to both organic and inorganic growth opportunities and they look forward to updating shareholders as their plans progress.

Catenai 0.25p £1.0m (CTAI.L)

The provider of digital media and technology announces its full year audited results for the year ended 31 December 2023. Revenue decreased to £28,670 (2022: £117,020), loss before tax decreased to £261,318 (2022: £545,533) and the cash and cash equivalents decreased to £1,185 (2022: £61,922). The Company continues to seek additional work from customers and develop the relationship with Klarian Ltd.

Ethernity Networks 0.95p £3.6m (ENET.L)

The supplier of data processing semiconductor technology for networking appliances, announces that it has secured a license agreement with a new Tier 1 US-based aerospace system products provider. The value is $1.05m total license fees, with majority of delivery expected to be completed during H2 2024. The Agreement will utilise Ethernity Networks' silicon-tuned software supporting specific networking capabilities on a Field-Programmable Gate Array device for the Customer's platform.

MediaZest * 0.0525p £0.9m (MDZ.L)

The creative audio-visual solutions provider announces its unaudited interim results for the six months ended 31 March 2024. Revenue has increased to £1.17m (H1 FY23: £1.05m), EBITDA loss has decreased to £28k (H1 FY23: £148k) and the cash balance has increased to £14k (H1 FY23: £10k). New business wins include installations in the Netherlands, Germany and France, to be delivered in H2 FY24 and the pipeline of potential new project work in Europe continues to expand. Positive outlook aiming to build on the progress in H1 and generate positive growth organically and targeting a return to profitability for the full financial year ending 30 September 2024, whilst continuing to evaluate suitable parties for a potential “Buy and build” acquisition.

OptiBiotix Health 16p £15.7m (OPTI.L)

A life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care announces its audited results for the 12 months ended 31 December 2023. Revenue for the year of £644k a 41% increase (2022: £457k), profit before tax decreased to loss £2.04m (2022: profit £2.44m) and the cash balance decreased to £635k (2022: £1.05m). The Company set out a strategy of developing first generation products using existing technology and highly innovative step change second generation products in parallel and commercialising these in global markets. The Company says this strategy gave shareholders exposure to multiple opportunities within the emerging global human microbiome space and the potential for multiple upside.

Proton Motor Power Systems 2.1p £34.9m (PPS.L)

The designer, developer and producer of fuel cells and fuel cell electric hybrid systems with a zero-carbon footprint announces its audited results for the year ended 31 December 2023. Revenue increased to £2.12m (2022: £2.09m), loss before tax decreased to £14.53m (2022: £18.90m) and the cash balance increased to £2.74m (2022: £2.72m). The Directors believe that the advanced stage of commercialisation of the Group's technology, coupled with the Group's preferred partnerships, will enable the business to establish itself firmly as a leading, global, fuel cell, fuel cell hybrid system provider.

Science in Sport 19p £34.2m (SIS.L)

The premium performance nutrition company serving elite athletes, sports enthusiasts, and the active lifestyle community announces its audited final results for the year ended 31 December 2023. Revenue decreased 1.7% to £62.7m (2022: £63.8m), loss before tax increased 6.6% to £11.8m (2022: £10.6m) and the cash balance increased to £2.14m (2022: £930k). The Board expects 2024 to be a year of progress as management continues to execute the strategic plan driving a balanced 2024 with the focus on controlled growth.

Surface Transforms 1.35p £17.6m (SCE.L)

Manufacturers of carbon fibre reinforced ceramic automotive brake discs announce its audited results for the twelve months ended 31 December 2023. Revenue increased 81% to £7.3m (2022: £4.0m), loss after tax including £9.2m impairment was £19.6m (2022: £5.3m) and Cash at 31 December 2023 of £6.1m (2022: £14.9m). The Company's ambition remains generating revenue of £100m sales per year within the next five years.

Tasty 1.2p £1.8m (TAST.L)

The owner and operator of restaurants in the casual dining sector announces its annual results for the 53 week period ended 31 December 2023. Revenue increased 6.5% to £46.9m (2022: £44.0m), Adjusted EBITDA increased to £4.4m (2022: £2.6m) and cash balance decreased to £4.18m (2022: £7.0m). Performance for the year to-date is behind management expectations, due largely to the cost of living crisis and the initial impact of the Restructuring Plan. However, the outlook post restructuring is positive.

Thruvision Group 17p £27.3m (THRU.L)

International provider of walk-through security technology today publishes its results for the financial year ended 31 March 2024. Revenue of £7.8m (2023: £12.4m), a reduction reflects previously announced lack of further significant orders from US Customs and Border Protection (CBP) in 2024. Adjusted EBITDA loss was £2.5m (2023: loss of £0.2m). The cash balance as at 31 March 2024 was £4.1m (31 March 2023: £2.8m). 2024 was undoubtedly a challenging year for Thruvision with the absence of a major contract award from our previously largest customer, CBP. However, the very strong revenue growth they achieved from customers outside CBP, and the fact that 70% of revenues came from existing customers provides an encouraging platform from which they can now return to growth.

.

28 June 2024
*A corporate client of Hybridan LLP or retained by Hybridan LLP for certain services
** Arranged by most recent first
*** Alphabetically arranged
**** Potential means Intention to Float (ITF) has been announced, or it is a rumour

STAY INFORMED

Our daily digest of news from UK listed Small and Mid caps straight to your Inbox.

Disclaimer

This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.

© Copyright 2024 - Hybridan | Website by Boxed Up Media
First Visit
bookcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram